Technical Analysis for FBLG - FibroBiologics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 11.49 | 1.68% | 0.19 |
FBLG closed up 1.68 percent on Wednesday, May 15, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Weak + Overbought | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Weak, Overbought and Reversal Signs | Reversal | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% |
| Alert | Time |
|---|---|
| Expansion Pivot Buy Entry | about 4 hours ago |
| Rose Above Previous Day's High | about 4 hours ago |
| Up 3% | about 8 hours ago |
| Up 2% | about 8 hours ago |
| Up 1% | about 8 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded in April 2021 and is headquartered in Houston, TX
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Stem Cell Chronic Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Stem Cell Chronic Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 55.0 |
| 52 Week Low | 6.53 |
| Average Volume | 67,254 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 10.55 |
| 20-Day Moving Average | 9.88 |
| 10-Day Moving Average | 9.33 |
| Average True Range | 1.28 |
| RSI (14) | 56.14 |
| ADX | 19.39 |
| +DI | 23.83 |
| -DI | 17.19 |
| Chandelier Exit (Long, 3 ATRs) | 8.01 |
| Chandelier Exit (Short, 3 ATRs) | 10.56 |
| Upper Bollinger Bands | 12.56 |
| Lower Bollinger Band | 7.20 |
| Percent B (%b) | 0.8 |
| BandWidth | 54.17 |
| MACD Line | -0.13 |
| MACD Signal Line | -0.44 |
| MACD Histogram | 0.3097 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 12.29 | ||||
| Resistance 3 (R3) | 12.32 | 12.09 | 12.15 | ||
| Resistance 2 (R2) | 12.09 | 11.89 | 12.07 | 12.11 | |
| Resistance 1 (R1) | 11.79 | 11.76 | 11.68 | 11.76 | 12.06 |
| Pivot Point | 11.56 | 11.56 | 11.50 | 11.54 | 11.56 |
| Support 1 (S1) | 11.26 | 11.36 | 11.15 | 11.23 | 10.92 |
| Support 2 (S2) | 11.03 | 11.23 | 11.01 | 10.87 | |
| Support 3 (S3) | 10.73 | 11.03 | 10.83 | ||
| Support 4 (S4) | 10.70 |
